X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
http://www.prnewswire.com/news-releases/xtl-biopharmaceuticals-advances-formulation-of-its-hcdr1-drug-for-clinical-trials-in-the-treatment-of-lupus-through-use-of-cydex-pharmaceuticals-captisol-565124681.html